AB0536 Tocilizumab offers clinical and ultrasonographic improvement in rheumatoid arthritis patients. Results of a 6 months follow-up study

Background Tocilizumab (TCZ) is a humanized anti-interleukin 6 (anti-IL 6) receptor antibody that has been demonstrated in previous clinical trials to improve rheumatoid arthritis (RA) and prevent radiographic progression. Musculoskeletal ultrasonography (MSUS) has increasingly been used as outcome...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of the rheumatic diseases 2013-06, Vol.71 (Suppl 3), p.669
Hauptverfasser: Bouaddi, I., Rkain, H., Aktaou, S., Raissouni, H., Traki, L., Bouazzaoui, L., Benchakroun, B., Benbrahim, L., Rostom, S., Allali, F., Bahiri, R., Amine, B., Benbouazza, K., Hajjaj-Hassouni, N.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!